Hepatocyte proliferation and hepatitis C virus kinetics during treatment

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 3, 2011, Pages 353-354

  Dahari, H ^a   Rong, L ^b   Layden, T J ^a   Cotler, S J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA; RIBAVIRIN; TELAPREVIR;

ANTIVIRAL THERAPY; CELL PROLIFERATION; CELL REGENERATION; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER CELL; LIVER WEIGHT; NONHUMAN; PRIORITY JOURNAL; HEPATITIS C; KINETICS; LIVER REGENERATION; RATE CONSTANT; TREATMENT RESPONSE;

ANIMALS; ANTIVIRAL AGENTS; CELL PROLIFERATION; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; KINETICS; MODELS, BIOLOGICAL;

EID: 79951811613     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.238     Document Type: Letter

References (5)

1. Snoeck, E. et al. A comprehensive hepatitis C viral kinetic model explaining cure. Clin. Pharmacol. Ther. 87, 706-713 (2010).
2. Pomfret, E.A. et al. Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation 76, 5-10 (2003).
3. Michalopoulos, G.K. & DeFrances, M.C. Liver regeneration. Science 276, 60-66 (1997).
4. Nadalin, S. et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl. 10, 1024-1029 (2004).
5. Rong, L., Dahari, H., Ribeiro, R.M. & Perelson, A .S. Rapid emergence of protease inhibitor resistance in hepatitis C virus. Sci. Transl. Med. 2, 30ra32 (2010).